Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China's PharmaLegacy Forms Musculoskeletal Alliance with BioVinc

publication date: Sep 6, 2016
PharmaLegacy Labs, a Shanghai pre-clinical CRO, recently formed a strategic alliance with Pasadena's BioVinc. Both companies have expertise in musculoskeletal drug development. BioVinc has developed a bone targeting platform based on its bisphosphonate research. It sells off-the-shelf and custom probes for bone disease, while also developing its own innovative drugs. PharmaLegacy offers CRO services in a number of areas, including bone/orthopedics. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital